Skip to content
Author: Lisa Gorelik
Posts by Lisa:
-
Psychedelics, Psychosocial Support, and Psychotherapy: Why It Matters for the Law, Ethics, and Business of Medical Psychedelic Use Posted on by Lisa Gorelik in Research
-
Time to Abolish the DEA: Evaluating the Agency’s Failures and Calling for Community Investments Posted on by Lisa Gorelik in Research
-
Introducing Petrie-Flom’s POPLAR and PULSE Affiliated Researchers on Psychedelics Posted on by Lisa Gorelik in News
-
Psychedelic therapies: healing for the wrong reasons? Posted on by Lisa Gorelik in Research
-
State Drug Laws Posted on by Lisa Gorelik in Research
-
Momentum is Not Enough: A Call for Consistency in Psychedelic Legislation Posted on by Lisa Gorelik in News
-
FDA rejects ecstasy as a therapy: what’s next for psychedelics? Posted on by Lisa Gorelik in News
-
FDA rejected MDMA-assisted PTSD therapy. Other psychedelics firms intend to avoid that fate Posted on by Lisa Gorelik in News
-
Getting to ‘Plan B’ for psychedelic medicine: Lessons from reproductive health Posted on by Lisa Gorelik in News
-
Psychedelic Therapy Scrutinized by FDA Advisory Committee? Posted on by Lisa Gorelik in Research
